Vincent Esguerra, MD
Basic profileThe Ohio State University Wexner Medical Center
Vincent Esguerra is a Respiratory physician affiliated with The Ohio State University Wexner Medical Center. OpenAlex indexes 17 publications with 218 citations (h-index 4).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
410 W 10th Ave
Columbus, OH 432101240
Telephone
614-293-4925Provider last certified this registry record 26 Feb 2026.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Insmed, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
39.2%Corticosteroid19.4%Symbicort22%Budesonide-Formoterol Fumarate21%Breo Ellipta20%Fluticasone Propionate19%Trelegy Ellipta10%Breyna8%Part D<11 patientsbeta2-Adrenergic Agonist9.2%Albuterol Sulfate Hfa100%Part D≥27 patients+ 4 more classes in this area
Cancer & immunology
24.8%Kinase inhibitor17.2%Ofev100%Part D≥23 patientsPyridone5.4%Pirfenidone100%Part D<11 patients+ 1 more class in this area
Metabolism & gastrointestinal
21.1%Corticosteroid16.7%Prednisone100%Part D≥49 patientsProton pump inhibitor2.7%Omeprazole100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Evaluating risk factors for Trastuzumab-Deruxtecan Pneumonitis in patients with metastatic breast cancer
Breast Cancer Research
2025 - Axatilimab Combination Therapies with Ruxolitinib and/or Belumosudil Induces Clinical Responses in Patients with Severe, Treatment-Refractory Chronic Gvhd
Biology of Blood and Marrow Transplantation
2025 - Evaluating Risk Factors for Trastuzumab-Deruxtecan Pneumonitis in Patients With Metastatic Breast Cancer
American Journal of Respiratory and Critical Care Medicine
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Timothy Pawlik, MD
The Ohio State University Wexner Medical Center
Colleen Cebulla, MD
The Ohio State University Wexner Medical Center
Michael Grever, MD
The Ohio State University Wexner Medical Center
Brad Rovin, MD
The Ohio State University Wexner Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”